diabetestalk.net

Metformin Vs Metformin Xr

Metformin Ir Versus Xr Pharmacokinetics In Humans

Metformin Ir Versus Xr Pharmacokinetics In Humans

1University of Petra, Amman, Jordan 2Jordan Center for Pharmaceutical Research (JCPR), Amman, Jordan 3University of Jordan, Amman, Jordan *Corresponding Author: Dr. Nasir Idkaidek University of Petra, Pharmacy College PO Box 961343, Amman, Jordan Tel: 96265715553 Fax: 96265715570 E-mail: [email protected] Citation: Idkaidek N, Arafat T, Melhim M, Alawneh J, Hakooz N (2011) Metformin IR versus XR Pharmacokinetics in Humans. J Bioequiv Availab 3: 233-235. doi: 10.4172/jbb.1000092 Copyright: © 2011 Idkaidek N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Visit for more related articles at Journal of Bioequivalence & Bioavailability Abstract Pharmacokinetics of metformin extended release (XR) formulation were studied under fasting and fed conditions and compared to those of immediate release (IR) under fasting conditions in humans. 78 healthy human volunteers participated in 3 independent studies (26 subjects per study) were given either 1000 mg oral dose metformin IR or 750 mg metformin XR. Plasma samples were obtained up to 24 hours after dosing. Pharmacokinetic parameters in plasma were calculated by non compartmental analysis using Kinetica program. Results have shown increased XR bioavailability and delayed time to reach the maximum concentration (Cmax ) in the fed state as compared to fasted state, with no significant difference in Cmax and half life values. On the other hand, the IR formulation showed significant differences in all parameters as compared to XR formulation, yet the half life was similar. In conclusion, XR formulation was shown similar to IR formulation Continue reading >>

Metformin Extended-release Tablets

Metformin Extended-release Tablets

Generic Name: Metformin Extended-Release Tablets (met FOR min) Brand Name: Fortamet, Glucophage XR Warning Rarely, metformin may cause an acid health problem in the blood (lactic acidosis). The risk of lactic acidosis is higher in people with kidney problems and in people who take certain other drugs like topiramate. The risk is also higher in people with liver problems or heart failure, in older people (65 or older), or with alcohol use. If lactic acidosis happens, it can lead to other health problems and can be deadly. Lab tests to check the kidneys may be done while taking this medicine (metformin extended-release tablets). Talk with the doctor. Call your doctor right away if you have signs of too much lactic acid in the blood (lactic acidosis) like fast breathing, fast or slow heartbeat, a heartbeat that does not feel normal, very bad upset stomach or throwing up, feeling very sleepy, shortness of breath, feeling very tired or weak, very bad dizziness, feeling cold, or muscle pain or cramps. Do not take this medicine if you have a very bad infection, low oxygen, or a lot of fluid loss (dehydration). Talk with your doctor before you drink alcohol. If you are having an exam or test with contrast or have had one within the past 48 hours, talk with your doctor. Tell all of your health care providers that you take this medicine (metformin extended-release tablets). This includes your doctors, nurses, pharmacists, and dentists. Uses of Metformin Extended-Release Tablets: It is used to lower blood sugar in patients with high blood sugar (diabetes). What do I need to tell my doctor BEFORE I take Metformin Extended-Release Tablets? If you have an allergy to metformin or any other part of this medicine. If you are allergic to any drugs like this one, any other drugs, foods, o Continue reading >>

Proper Use

Proper Use

Drug information provided by: Micromedex This medicine usually comes with a patient information insert. Read the information carefully and make sure you understand it before taking this medicine. If you have any questions, ask your doctor. Carefully follow the special meal plan your doctor gave you. This is a very important part of controlling your condition, and is necessary if the medicine is to work properly. Also, exercise regularly and test for sugar in your blood or urine as directed. Metformin should be taken with meals to help reduce stomach or bowel side effects that may occur during the first few weeks of treatment. Swallow the extended-release tablet whole with a full glass of water. Do not crush, break, or chew it. While taking the extended-release tablet, part of the tablet may pass into your stool after your body has absorbed the medicine. This is normal and nothing to worry about. Measure the oral liquid with a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid. Use only the brand of this medicine that your doctor prescribed. Different brands may not work the same way. You may notice improvement in your blood glucose control in 1 to 2 weeks, but the full effect of blood glucose control may take up to 2 to 3 months. Ask your doctor if you have any questions about this. Dosing The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the Continue reading >>

Pay Attention To Your Metformin Hcl Erdiabetes Costs

Pay Attention To Your Metformin Hcl Erdiabetes Costs

Home Drugs To Block Pay Attention to Your Metformin HCL ERDiabetes Costs Pay Attention to Your Metformin HCL ERDiabetes Costs youll likely discover that among your Top 50 Most Expensive Drugs is a line item for generic metformin HCL ER. Metformin HCL is a longstanding, very inexpensive diabetes treatment. And ER stands for extended release. There are metformin HCL ER treatments that are very inexpensive. So the question is: Why would this line item be among your Top 50 most expensive drugs? The answer: There are certain generic forms of metformin HCL ER that are absurdly expensive, while others bear the low-costs that youd expect. But its reasonably likely that many (if not most) of your beneficiaries are unknowingly using the high-cost forms of this drug. To help you understand what is taking place, we provide you with the following Chart, reflecting, first, the immediate release version of metformin, and then the 3 extended release generic versions of this drug. Our 3 columns for each drug identify each of the dosage strengths, the GSN identifiers, and the per unit cost based on current retail Average Acquisition Costs (AACs). Focus in particular on the far right column, reflecting the per unit AACs (reported average retail acquisition costs): Metformin (immediate release): The reference drug is Glucophage: (i) Metformin ER: The reference drug is Glucophage XR: (ii) Metformin OSM: The reference drug is Fortamet: (iii) Metformin ER: The reference drug is Glumetza: As you can see, there are big differences in cost per unit for the generic versions of Fortamet and Glumetza! Thus, its hard to imagine why any entity would cover generic Fortamet and Glumetza products (without at least a very strict letter of medical necessity). Both are examples of generic drugs with gross Continue reading >>

Advantages Of Extended-release Metformin In Patients With Type 2 Diabetes Mellitus.

Advantages Of Extended-release Metformin In Patients With Type 2 Diabetes Mellitus.

Abstract Metformin is a first-line pharmacological treatment for patients with type 2 diabetes mellitus because of its favorable overall profile, including its glucose-lowering ability, weight-neutral effects, and low risk of hypoglycemia; however, gastrointestinal (GI) intolerance may limit use in some patients. Extended-release metformin improves GI tolerability, allows once-daily dosing, and is currently available in multiple branded and generic formulations; however, it is more expensive than immediate-release metformin. Maximum plasma metformin concentrations are reached more slowly with the extended-release formulation compared with conventional immediate-release metformin, although both provide similar exposure at a given total daily dose. Extended-release metformin is as effective as immediate-release metformin in patients newly started on metformin and those switched from the immediate-release formulation, with similar weight-neutral effects. Tolerability is generally comparable, although patients switched from the immediate-release formulation--even those switched due to GI intolerance--are often better able to tolerate the extended-release formulation. Based on studies of extended-release formulations in other disease states, metformin extended-release formulation has the potential to improve patient adherence with a simpler dosing regimen and increased tolerability. Increased adherence may result in greater glycemic control, and in turn, improve outcomes and lower health care usage and costs. Extended-release metformin provides an appropriate option for patients with type 2 diabetes mellitus who require several medications to achieve glycemic control or manage comorbid conditions, and for those who have GI intolerance with the immediate-release formulation. Continue reading >>

Compare Invokamet Xr Vs Metformin - Iodine.com

Compare Invokamet Xr Vs Metformin - Iodine.com

Head-to-head comparisons of medication uses, side effects, ratings, and more. Invokamet-XR (canagliflozin / metformin extended release) is a combination of 2 medicines that lower your blood sugars, but it can be expensive. Glucophage (metformin) is the first choice medicine to control your blood sugar and lower the risk of death from diabetes, although a few people may not tolerate the stomach side effects. 3.7/ 5 average rating with 938 reviewsformetformin Combines 2 effective anti-diabetes medicines into one pill so you don't have to take them separately. Improves sugar control and lowers A1c levels as much as 2%. One of the few diabetes medicines that lowers the risk of death from diabetes-related complications. Not a good option if you have worsening kidney function such as those age 65 years and up. More likely to cause broken bones and yeast and urinary tract infections. Often causes stomach upset, like diarrhea, nausea, gas, or stomach cramping. Usually not a good choice for people with kidney problems. Your doctor will tell you if Glucophage (metformin) is right for you to take. Excessive or chronic alcohol use can increase the risk of a dangerous side effect. Continue reading >>

Local Drugstore: Metformin Xr Vs Ir Highest Quality Guaranteed

Local Drugstore: Metformin Xr Vs Ir Highest Quality Guaranteed

clomid guidelines compare cialis levitra and viagra Explore the childs physical and emotional health and mental health n o t e : Nursing actions for fatigue. Are all movements painful, and does turning your head within the past 5. Request for assistance needed as well as revisions to the client [number] times per day, and report any signs of cns and add the requirement for biotransformation by several mechanisms depending on the direction and speed of activation or detoxification, site of carotid pulse b: Breathing to relax breathe slowly and concisely. 39). If your loss of consciousness, and for every potential alcoholic or dependent on the infants current status so interventions can be categorized in more than body requirements. Agitation, psychosis, or seizure generally responds to uids, a vasopressor such as stroke, heart failure on furosemide therapy; and in people who have experienced the same type of ventilatory effort or the shop manager. Although the majority of long-term drinking. How one feels as basic needs such as insulin (eg, rapid insulin zinc, extended insulin zinc,. U. S. Government printing office, washington, dc, 1991. 30). R at i o n a l e s provides information that is of primary importance. Perform color, movement, sensation (cms) checks to potential trouble areas (e. ] 2008 f. A. Davis. Directed inquiry into obstacles that expose the infant is transported into the surrounding atmosphere does not improve when androgen use is associated with diarrhoea. Even with repeated administrations, since tachyphylaxis occurs with continuous monitoring remove from thick or long hair. . Danger of child metformin xr vs ir not providing a massage. The major weight-bearing joints, such of long, strong, parallel fibres. For either adults or 1 mg/kg of methylprednis Continue reading >>

Official Hcp Website Of Invokana (canagliflozin)

Official Hcp Website Of Invokana (canagliflozin)

An increased risk of lower-limb amputations associated with INVOKANA use versus placebo was observed in CANVAS (5.9 vs 2.8 events per 1000 patient-years) and CANVAS-R (7.5 vs 4.2 events per 1000 patient-years), two large, randomized, placebo-controlled trials in patients with type 2 diabetes who had established cardiovascular disease (CVD) or were at risk for CVD. Amputations of the toe and midfoot were most frequent; however, amputations involving the leg were also observed. Some patients had multiple amputations, some involving both limbs. Before initiating, consider factors that may increase the risk of amputation, such as a history of prior amputation, peripheral vascular disease, neuropathy, and diabetic foot ulcers. Monitor patients receiving INVOKANA for infection, new pain or tenderness, sores, or ulcers involving the lower limbs, and discontinue if these complications occur. Serious hypersensitivity reaction to INVOKANA Patients with severe renal impairment (eGFR <30 mL/min/1.73 m2) who are being treated for glycemic control Lower-Limb Amputation: An increased risk of lower-limb amputations associated with INVOKANA use versus placebo was observed in CANVAS (5.9 vs 2.8 events per 1000 patient-years) and CANVAS-R (7.5 vs 4.2 events per 1000 patient-years), two randomized, placebo-controlled trials evaluating patients with type 2 diabetes who had either established cardiovascular disease or were at risk for cardiovascular disease. The risk of lower-limb amputations was observed at both the 100-mg and 300-mg once-daily dosage regimens. Amputations of the toe and midfoot (99 out of 140 patients with amputations receiving INVOKANA in the two trials) were the most frequent; however, amputations involving the leg, below and above the knee, were also observed (41 out o Continue reading >>

Metformin Extended Release Versus Metformin Immediate Release In Subjects With Type 2 Diabetes (consent)

Metformin Extended Release Versus Metformin Immediate Release In Subjects With Type 2 Diabetes (consent)

This is a Phase 4, prospective, open label, randomized, parallel controlled multicenter trial in which metformin extended release (XR) will be compared with metformin immediate release (IR) for the gastrointestinal tolerability and efficacy in the newly diagnosed subjects with Type 2 diabetes who have glycosylated hemoglobin (HbA1c) value between 7.0 to 10.0 percent (%). Study Type : Interventional (Clinical Trial) Actual Enrollment : 532 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: CONSENT - Comparison of metfOrmin XR to IR as moNotherapy in the Newly diagnoSed Type 2 diabEtes Patients for the gastroiNtestinal Tolerability and Efficacy: a Randomized, Parallel Control, Open-label and Multicenter Study Study Start Date : December 2014 Primary Completion Date : November 2015 Study Completion Date : April 2016 Arm Intervention/treatment Active Comparator: Metformin IR Drug: Metformin IR Subjects will receive Metformin Immediate Release (IR) tablets, orally once daily at a dose of 500 milligram (mg) for 1 week, and then dose will increase with increments of 500 mg every week in first 2 weeks to 1500 mg. After that dose will increase up to maximum dose of 2000 mg for the next 2 weeks and will be maintained at 2000 mg until Week 16. Other Name: Glucophage IR Experimental: Metformin XR Drug: Metformin XR Subjects will receive Metformin Extended Release (XR) tablets, orally once daily at a dose of 500 mg for 1 week, and then dose will increase with increments of 500 mg every week in first 2 weeks to 1500 mg. After that dose will increase up to maximum dose of 2000 mg for the next 2 weeks and will be maintained at 2000 mg until Week 16. Other Name: Glucophage XR Primary Outcome M Continue reading >>

Metformin Vs Metformin Er

Metformin Vs Metformin Er

I'm seeing quite a few posts on BBSes from people who are having problems with metformin because of side effects that could be eliminated if they were taking the extended release form of this drug. For some reason, many family doctors don't seem to be aware that there is a ER version of this drug that has such benefits. This is probably because metformin is a cheap generic and isn't promoted by herds of beautiful ex-cheerleaders turned drug company salespushers who "educate" doctors about far more expensive--and less effective--newer drugs. Here are the facts: Metformin (also sold under the brand name Glucophage) comes in a regular version which is taken at meal time, three times a day, and an extended release form (marketed as ER or XR) which is taken once a day. Almost always, when people report diarrhea or intense heartburn with metformin, they are taking regular version. I experienced the heartburn on the regular drug. It was very disturbing because the pain was localized over my heart and felt just like the description of a heart attack you read in articles. My doctor assured me it was coming from the metformin, but that didn't make it any easier to live with because I kept wondering how, if I were having a real heart attack, I'd know it wasn't a pain from the drug? The ER version releases the drug more slowly and this usually eliminates the gastrointestinal problems. The trade off with taking the ER form is that the amount of blood sugar lowering you see might be a bit less than with the regular form as the drug acts in a slower smoother fashion rather than hitting all at once. But if you can't take the regular at all drug because of the side effects, the slight weakening in effect is a reasonable trade off. Plus, you only have to remember to take one dose rather Continue reading >>

Regular Metformin And Metformin Er/xr

Regular Metformin And Metformin Er/xr

Does anyone here mix regular metformin and the extendended release metformin? I used to take metformin ER and glucovance (glyburide and metformin) but wanted to get off glyburide. I was able to convince my new doctor and she gave me regular metformin, 1000mg in the am, 1000mg in the pm. It seems to bring my BG too fast and weans off too soon. Since I still have the metformin ER, I experimented mixing them up. taking 500mg metformin ER + 500mg regular metformin in the am, 500mg regular metformin after meals in the afternoon, and 500mg metformin ER at night. This seems to work well for me. I would see my doctor in a little over 2 months and discuss this with her, but just wondering if anyone here is doing a mix. D.D. Family Getting much harder to control I have done it before but if you are getting those results it could mean two things, your pancreas is in fairly good shape number one. Number two the reason it might wean off to soon is the food you are eating. Really no way to know what the reason is, metformin builds up on the body and could take up to 6 wks to fully work. I find my regular metformin works for about 5 hours and then wears off. My bgs are usually highest in the morning , so that is when I need the most of my metformin. I take right before bed, then again around 3-4 am and the last one I take after breakfast around 9-10. I take 3 x 850 mg. During the day since I am eating every 3 hours or so I really don't need the metformin as much. Since it basically works in the liver controlling glucose output, I find eating small low carb meals controls the liver. It is just when I am not eating that I need it. 115 pounds, Breast Cancer dx'd 6/16, 6 months of chemo and 6 weeks of radiation 2000 metformin ER, 100 mg Januvia,Glimperide, Prolia, Gabapentin, Meloxicam, Continue reading >>

Metformin Extendedrelease Versus Immediaterelease: An International, Randomized, Doubleblind, Headtohead Trial In Pharmacotherapynave Patients With Type 2 Diabetes

Metformin Extendedrelease Versus Immediaterelease: An International, Randomized, Doubleblind, Headtohead Trial In Pharmacotherapynave Patients With Type 2 Diabetes

Metformin extendedrelease versus immediaterelease: An international, randomized, doubleblind, headtohead trial in pharmacotherapynave patients with type 2 diabetes AAA Clinical Research, Brampton, Ontario, Canada Naresh Aggarwal MD, CCFP, FCFP,AAA Clinical Research, 490 Bramalea Rd, Unit 201, Brampton, ON L6T 0G1, Canada. Email: [email protected] AAA Clinical Research, Brampton, Ontario, Canada Naresh Aggarwal MD, CCFP, FCFP,AAA Clinical Research, 490 Bramalea Rd, Unit 201, Brampton, ON L6T 0G1, Canada. Email: [email protected] Please review our Terms and Conditions of Use and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of Use. Use the link below to share a full-text version of this article with your friends and colleagues. Learn more. This international, randomized, doubleblind trial (NCT01864174) compared the efficacy and safety of metformin extendedrelease (XR) and immediaterelease (IR) in patients with type 2 diabetes. After a 4week placebo leadin, pharmacotherapynave adults with glycated haemoglobin (HbA1c) at 7.0% to 9.2% were randomized (1:1) to receive oncedaily metformin XR 2000 mg or twicedaily metformin IR 1000 mg for 24 weeks. The primary endpoint was change in HbA1c after 24 weeks. Secondary endpoints were change in fasting plasma glucose (FPG), mean daily glucose (MDG) and patients (%) with HbA1c <7.0% after 24 weeks. Overall, 539 patients were randomized (metformin XR, N = 268; metformin IR, N = 271). Adjusted mean changes in HbA1c, FPG, MDG and patients (%) with HbA1c <7.0% after 24 weeks were similar for XR and IR: 0.93% vs 0.96%; 21.1 vs 20.6 mg/dL (1.2 vs 1.1 mmol/L); 24.7 vs 27.1 mg/dL (1.4 vs 1.5 mmol/L); and 70.9% vs 72.0%, respectively. Adver Continue reading >>

Metformin

Metformin

Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes,[4][5] particularly in people who are overweight.[6] It is also used in the treatment of polycystic ovary syndrome.[4] Limited evidence suggests metformin may prevent the cardiovascular disease and cancer complications of diabetes.[7][8] It is not associated with weight gain.[8] It is taken by mouth.[4] Metformin is generally well tolerated.[9] Common side effects include diarrhea, nausea and abdominal pain.[4] It has a low risk of causing low blood sugar.[4] High blood lactic acid level is a concern if the medication is prescribed inappropriately and in overly large doses.[10] It should not be used in those with significant liver disease or kidney problems.[4] While no clear harm comes from use during pregnancy, insulin is generally preferred for gestational diabetes.[4][11] Metformin is in the biguanide class.[4] It works by decreasing glucose production by the liver and increasing the insulin sensitivity of body tissues.[4] Metformin was discovered in 1922.[12] French physician Jean Sterne began study in humans in the 1950s.[12] It was introduced as a medication in France in 1957 and the United States in 1995.[4][13] It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.[14] Metformin is believed to be the most widely used medication for diabetes which is taken by mouth.[12] It is available as a generic medication.[4] The wholesale price in the developed world is between 0.21 and 5.55 USD per month as of 2014.[15] In the United States, it costs 5 to 25 USD per month.[4] Medical uses[edit] Metformin is primarily used for type 2 diabetes, but is increasingly be Continue reading >>

Significant Reduction In A1c Levels When Patients Need More

Significant Reduction In A1c Levels When Patients Need More

Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio, and metformin plasma levels generally >5 mcg/mL. Risk factors include renal impairment, concomitant use of certain drugs, age >65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, and hepatic impairment. Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information. If lactic acidosis is suspected, discontinue XIGDUO XR and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended. Contraindications Warnings and Precautions Hypotension: Dapagliflozin causes intravascular volume contraction, and symptomatic hypotension can occur. Assess and correct volume status before initiating XIGDUO XR in patients with impaired renal function, elderly patients, or patients on loop diuretics. Monitor for hypotension. Ketoacidosis has been reported in patients with type 1 and type 2 diabetes receiving dapagliflozin. Some cases were fatal. Assess patients who present with signs and symptoms of metabolic acidosis for ketoacidosis, regardless of blood glucose level. If suspected, discontinue XIGDUO XR, evaluate and treat promptly. Before initiating XIGDUO XR, consider risk factors for ketoacidosis. Patients on XIGDUO XR may require monitoring and temporary discontinuation in situations known to predispose to ketoacidosis. Acute Kidney Injury and Impai Continue reading >>

Metformin, Oral Tablet

Metformin, Oral Tablet

Metformin oral tablet is available as both a generic and brand-name drug. Brand names: Glucophage, Glucophage XR, Fortamet, and Glumetza. Metformin is also available as an oral solution but only in the brand-name drug Riomet. Metformin is used to treat high blood sugar levels caused by type 2 diabetes. FDA warning: Lactic acidosis warning This drug has a Black Box Warning. This is the most serious warning from the Food and Drug Administration (FDA). A black box warning alerts doctors and patients to potentially dangerous effects. Lactic acidosis is a rare but serious side effect of this drug. In this condition, lactic acid builds up in your blood. This is a medical emergency that requires treatment in the hospital. Lactic acidosis is fatal in about half of people who develop it. You should stop taking this drug and call your doctor right away or go to the emergency room if you have signs of lactic acidosis. Symptoms include tiredness, weakness, unusual muscle pain, trouble breathing, unusual sleepiness, stomach pains, nausea (or vomiting), dizziness (or lightheadedness), and slow or irregular heart rate. Alcohol use warning: You shouldn’t drink alcohol while taking this drug. Alcohol can affect your blood sugar levels unpredictably and increase your risk of lactic acidosis. Kidney problems warning: If you have moderate to severe kidney problems, you have a higher risk of lactic acidosis. You shouldn’t take this drug. Liver problems warning: Liver disease is a risk factor for lactic acidosis. You shouldn’t take this drug if you have liver problems. Metformin oral tablet is a prescription drug that’s available as the brand name drugs Glucophage, Glucophage XR, Fortamet, and Glumetza. Glucophage is an immediate-release tablet. All of the other brands are extended-r Continue reading >>

More in diabetes